speb/financial-data huggingface dataset:
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -79282000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 736757000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 736757000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 9586734000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 9586734000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Gross Profit: 2854520000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 862505000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Interest Expense: 132587000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 30912000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 132587000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 30912000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -18945000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 105835000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Inventory: 2564114000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2564114000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 16452630000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 16452630000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -2852744000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 562673000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 562673000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 47248000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 47248000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 3277270000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3277270000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3324518000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3324518000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 117040000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 117040000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Net Debt: 3504700000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 3504700000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -77137000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Income: 205470000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Income: 237802000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 205470000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 237802000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 205470000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 237802000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 205470000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 237802000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 205470000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 237802000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 203554000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 205470000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 237802000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Interest Income: -132587000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -30912000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 786747000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 1718748000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 1847271000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -132587000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -30912000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Net PPE: 9586734000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 9586734000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3745326000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -128523000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 12141093000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 12141093000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 763016000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 342066000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Normalized Income: 244911000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 232410402.27
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1011953000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Operating Income: 1585301000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Operating Income: 565045000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Operating Revenue: 8113273000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2376073000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 50719105.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 50719105.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 766692000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 766692000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 187994000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 187994000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 12370659000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 12370659000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 736757000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 736757000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 48559000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 896842000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 896842000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: -1176812000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -311657000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Properties: 6181523000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 6181523000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 770660000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 770660000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Payables: 2299025000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2299025000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Pretax Income: 210167000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 227868000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 6849000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3835810000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 5258753000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1513568000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 354527000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 88678000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 90484000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Share Issued: 50719105.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 50719105.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Special Income Charges: -65735000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 5392000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 12877850000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12877850000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 12141093000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 12141093000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -26294000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 402.27
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Tax Provision: -1916000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 17000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs:
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 25801000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 25801000.00
ORCHPHARMA.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: 26826000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Assets: 19109109000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 19109109000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 16155120000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 16155120000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Debt: 3625882000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 3625882000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 12877850000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12877850000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Total Expenses: 6527972000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1811028000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 6231259000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6231259000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 12270123000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 12270123000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3441558000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3441558000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -65735000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 5392000.00
ORCHPHARMA.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -65735000.00
ORCHPHARMA.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 5392000.00
ORCHPHARMA.NS balance_sheet (annual, 2026-03-31) — Working Capital: 4049285000.00
ORCHPHARMA.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 4049285000.00
ORCL balance_sheet (annual, 2021-05-31) — Non Current Deferred Liabilities: 7864000000.00
ORCL balance_sheet (annual, 2021-05-31) — Non Current Deferred Taxes Liabilities: 7864000000.00
ORCL balance_sheet (annual, 2021-05-31) — Other Current Borrowings: 8250000000.00
ORCL income_statement (annual, 2021-05-31) — Other Operating Expenses: 129000000.00
ORCL balance_sheet (annual, 2021-05-31) — Prepaid Assets: 3604000000.00
ORCL cash_flow (annual, 2021-05-31) — Provisionand Write Offof Assets: 192000000.00
ORCL cash_flow (annual, 2021-05-31) — Short Term Debt Issuance: 0.00
ORCL income_statement (annual, 2022-05-31) — +Operating Expense: 17733000000.00
ORCL income_statement (annual, 2022-05-31) — +Total Revenue: 42440000000.00
ORCL balance_sheet (annual, 2022-05-31) — Accounts Payable: 1317000000.00
ORCL balance_sheet (annual, 2022-05-31) — Accounts Receivable: 5953000000.00
ORCL balance_sheet (annual, 2022-05-31) — Accumulated Depreciation: -9958000000.00
ORCL balance_sheet (annual, 2022-05-31) — Allowance For Doubtful Accounts Receivable: -362000000.00
ORCL income_statement (annual, 2022-05-31) — Amortization: 1150000000.00
ORCL cash_flow (annual, 2022-05-31) — Amortization Cash Flow: 1150000000.00
ORCL cash_flow (annual, 2022-05-31) — Amortization Of Intangibles: 1150000000.00
ORCL income_statement (annual, 2022-05-31) — Amortization Of Intangibles Income Statement: 1150000000.00
ORCL income_statement (annual, 2022-05-31) — Basic Average Shares: 2700000000.00
ORCL income_statement (annual, 2022-05-31) — Basic EPS: 2.49
ORCL cash_flow (annual, 2022-05-31) — Beginning Cash Position: 30098000000.00
ORCL balance_sheet (annual, 2022-05-31) — Buildings And Improvements: 4729000000.00
ORCL cash_flow (annual, 2022-05-31) — Capital Expenditure: -4511000000.00
ORCL cash_flow (annual, 2022-05-31) — Capital Expenditure Reported: -4511000000.00
ORCL balance_sheet (annual, 2022-05-31) — Capital Stock: 26808000000.00
ORCL balance_sheet (annual, 2022-05-31) — Cash And Cash Equivalents: 21383000000.00
ORCL balance_sheet (annual, 2022-05-31) — Cash Cash Equivalents And Short Term Investments: 21902000000.00
ORCL cash_flow (annual, 2022-05-31) — Cash Dividends Paid: -3457000000.00
ORCL cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Financing Activities: -29126000000.00
ORCL cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Investing Activities: 11220000000.00
ORCL cash_flow (annual, 2022-05-31) — Cash Flow From Continuing Operating Activities: 9539000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Account Payable: -733000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Income Tax Payable: -398000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Other Working Capital: 7000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Payable: -1131000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Payables And Accrued Expense: -1131000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Prepaid Assets: 11000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Receivables: -874000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Tax Payable: -398000000.00
ORCL cash_flow (annual, 2022-05-31) — Change In Working Capital: -1987000000.00
ORCL cash_flow (annual, 2022-05-31) — Changes In Account Receivables: -874000000.00
ORCL cash_flow (annual, 2022-05-31) — Changes In Cash: -8367000000.00
ORCL balance_sheet (annual, 2022-05-31) — Common Stock: 26808000000.00
ORCL cash_flow (annual, 2022-05-31) — Common Stock Dividend Paid: -3457000000.00
ORCL balance_sheet (annual, 2022-05-31) — Common Stock Equity: -6220000000.00
ORCL cash_flow (annual, 2022-05-31) — Common Stock Issuance: 482000000.00
ORCL cash_flow (annual, 2022-05-31) — Common Stock Payments: -17341000000.00
ORCL balance_sheet (annual, 2022-05-31) — Construction In Progress: 512000000.00
ORCL income_statement (annual, 2022-05-31) — Cost Of Revenue: 8877000000.00
ORCL balance_sheet (annual, 2022-05-31) — Current Assets: 31633000000.00
ORCL balance_sheet (annual, 2022-05-31) — Current Debt: 3749000000.00
ORCL balance_sheet (annual, 2022-05-31) — Current Debt And Capital Lease Obligation: 3749000000.00
ORCL balance_sheet (annual, 2022-05-31) — Current Deferred Liabilities: 8357000000.00
ORCL balance_sheet (annual, 2022-05-31) — Current Deferred Revenue: 8357000000.00
ORCL balance_sheet (annual, 2022-05-31) — Current Liabilities: 19511000000.00
ORCL cash_flow (annual, 2022-05-31) — Deferred Income Tax: -1146000000.00
ORCL cash_flow (annual, 2022-05-31) — Deferred Tax: -1146000000.00
ORCL cash_flow (annual, 2022-05-31) — Depreciation: 1972000000.00
ORCL cash_flow (annual, 2022-05-31) — Depreciation Amortization Depletion: 3122000000.00
ORCL income_statement (annual, 2022-05-31) — Depreciation Amortization Depletion Income Statement: 1150000000.00
ORCL cash_flow (annual, 2022-05-31) — Depreciation And Amortization: 3122000000.00
ORCL income_statement (annual, 2022-05-31) — Depreciation And Amortization In Income Statement: 1150000000.00
ORCL balance_sheet (annual, 2022-05-31) — Derivative Product Liabilities: -23000000.00
ORCL income_statement (annual, 2022-05-31) — Diluted Average Shares: 2786000000.00
ORCL income_statement (annual, 2022-05-31) — Diluted EPS: 2.41
ORCL income_statement (annual, 2022-05-31) — Diluted NI Availto Com Stockholders: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — EBIT: 10404000000.00
ORCL income_statement (annual, 2022-05-31) — EBITDA: 13526000000.00
ORCL income_statement (annual, 2022-05-31) — Earnings From Equity Interest: -184000000.00
ORCL cash_flow (annual, 2022-05-31) — Effect Of Exchange Rate Changes: -348000000.00
ORCL cash_flow (annual, 2022-05-31) — End Cash Position: 21383000000.00
ORCL cash_flow (annual, 2022-05-31) — Financing Cash Flow: -29126000000.00
ORCL cash_flow (annual, 2022-05-31) — Free Cash Flow: 5028000000.00
ORCL income_statement (annual, 2022-05-31) — Gain On Sale Of Security: -346000000.00
ORCL balance_sheet (annual, 2022-05-31) — Gains Losses Not Affecting Retained Earnings: -1692000000.00
ORCL income_statement (annual, 2022-05-31) — General And Administrative Expense: 1317000000.00
ORCL balance_sheet (annual, 2022-05-31) — Goodwill: 43811000000.00
ORCL balance_sheet (annual, 2022-05-31) — Goodwill And Other Intangible Assets: 45251000000.00
ORCL balance_sheet (annual, 2022-05-31) — Gross Accounts Receivable: 6315000000.00
ORCL balance_sheet (annual, 2022-05-31) — Gross PPE: 19674000000.00
ORCL income_statement (annual, 2022-05-31) — Gross Profit: 33563000000.00
ORCL cash_flow (annual, 2022-05-31) — Income Tax Paid Supplemental Data: 2567000000.00
ORCL income_statement (annual, 2022-05-31) — Interest Expense: 2755000000.00
ORCL income_statement (annual, 2022-05-31) — Interest Expense Non Operating: 2755000000.00
ORCL income_statement (annual, 2022-05-31) — Interest Income: 94000000.00
ORCL income_statement (annual, 2022-05-31) — Interest Income Non Operating: 94000000.00
ORCL cash_flow (annual, 2022-05-31) — Interest Paid Supplemental Data: 2735000000.00
ORCL balance_sheet (annual, 2022-05-31) — Invested Capital: 69639000000.00
ORCL cash_flow (annual, 2022-05-31) — Investing Cash Flow: 11220000000.00
ORCL cash_flow (annual, 2022-05-31) — Issuance Of Capital Stock: 482000000.00
ORCL cash_flow (annual, 2022-05-31) — Issuance Of Debt: 0.00
ORCL balance_sheet (annual, 2022-05-31) — Land And Improvements: 1166000000.00
ORCL balance_sheet (annual, 2022-05-31) — Long Term Debt: 72110000000.00
ORCL balance_sheet (annual, 2022-05-31) — Long Term Debt And Capital Lease Obligation: 72110000000.00
ORCL cash_flow (annual, 2022-05-31) — Long Term Debt Issuance: 0.00
ORCL cash_flow (annual, 2022-05-31) — Long Term Debt Payments: -8250000000.00
ORCL balance_sheet (annual, 2022-05-31) — Machinery Furniture Equipment: 13267000000.00
ORCL balance_sheet (annual, 2022-05-31) — Minority Interest: 452000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Business Purchase And Sale: -148000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Common Stock Issuance: -16859000000.00
ORCL balance_sheet (annual, 2022-05-31) — Net Debt: 54476000000.00
ORCL income_statement (annual, 2022-05-31) — Net Income: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — Net Income Common Stockholders: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — Net Income Continuous Operations: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — Net Income From Continuing And Discontinued Operation: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — Net Income From Continuing Operation Net Minority Interest: 6717000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Income From Continuing Operations: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — Net Income Including Noncontrolling Interests: 6717000000.00
ORCL income_statement (annual, 2022-05-31) — Net Interest Income: -2661000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Investment Purchase And Sale: 15879000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Issuance Payments Of Debt: -8250000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Long Term Debt Issuance: -8250000000.00
ORCL income_statement (annual, 2022-05-31) — Net Non Operating Interest Income Expense: -2661000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Other Financing Charges: -560000000.00
ORCL balance_sheet (annual, 2022-05-31) — Net PPE: 9716000000.00
ORCL cash_flow (annual, 2022-05-31) — Net Short Term Debt Issuance: 0.00
ORCL balance_sheet (annual, 2022-05-31) — Net Tangible Assets: -51471000000.00
ORCL balance_sheet (annual, 2022-05-31) — Non Current Deferred Assets: 12782000000.00
ORCL balance_sheet (annual, 2022-05-31) — Non Current Deferred Liabilities: 6031000000.00
ORCL balance_sheet (annual, 2022-05-31) — Non Current Deferred Taxes Assets: 12782000000.00
ORCL balance_sheet (annual, 2022-05-31) — Non Current Deferred Taxes Liabilities: 6031000000.00
ORCL income_statement (annual, 2022-05-31) — Normalized EBITDA: 18776000000.00
ORCL income_statement (annual, 2022-05-31) — Normalized Income: 11326500000.00
ORCL cash_flow (annual, 2022-05-31) — Operating Cash Flow: 9539000000.00
ORCL income_statement (annual, 2022-05-31) — Operating Income: 15830000000.00
ORCL income_statement (annual, 2022-05-31) — Operating Revenue: 42440000000.00
ORCL balance_sheet (annual, 2022-05-31) — Ordinary Shares Number: 2665000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Current Assets: 3778000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Current Borrowings: 3749000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Current Liabilities: 4144000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Equity Adjustments: -1692000000.00
ORCL income_statement (annual, 2022-05-31) — Other Gand A: 1317000000.00
ORCL income_statement (annual, 2022-05-31) — Other Income Expense: -5520000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Intangible Assets: 1440000000.00
ORCL cash_flow (annual, 2022-05-31) — Other Non Cash Items: 220000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Non Current Assets: 9915000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Non Current Liabilities: 5203000000.00
ORCL income_statement (annual, 2022-05-31) — Other Non Operating Income Expenses: -86000000.00
ORCL income_statement (annual, 2022-05-31) — Other Operating Expenses: 4694000000.00
ORCL balance_sheet (annual, 2022-05-31) — Other Short Term Investments: 519000000.00
ORCL balance_sheet (annual, 2022-05-31) — Payables: 1317000000.00
ORCL balance_sheet (annual, 2022-05-31) — Payables And Accrued Expenses: 1317000000.00
ORCL balance_sheet (annual, 2022-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 1944000000.00
ORCL balance_sheet (annual, 2022-05-31) — Preferred Stock: 0.00
ORCL balance_sheet (annual, 2022-05-31) — Prepaid Assets: 3778000000.00
ORCL income_statement (annual, 2022-05-31) — Pretax Income: 7649000000.00
ORCL balance_sheet (annual, 2022-05-31) — Properties: 0.00
ORCL cash_flow (annual, 2022-05-31) — Purchase Of Business: -148000000.00
ORCL cash_flow (annual, 2022-05-31) — Purchase Of Investment: -10272000000.00
ORCL balance_sheet (annual, 2022-05-31) — Receivables: 5953000000.00
ORCL income_statement (annual, 2022-05-31) — Reconciled Cost Of Revenue: 6905000000.00
ORCL income_statement (annual, 2022-05-31) — Reconciled Depreciation: 3122000000.00
ORCL cash_flow (annual, 2022-05-31) — Repayment Of Debt: -8250000000.00
ORCL cash_flow (annual, 2022-05-31) — Repurchase Of Capital Stock: -17341000000.00
ORCL income_statement (annual, 2022-05-31) — Research And Development: 7219000000.00
ORCL income_statement (annual, 2022-05-31) — Restructuring And Mergern Acquisition: 4904000000.00
ORCL balance_sheet (annual, 2022-05-31) — Retained Earnings: -31336000000.00
ORCL income_statement (annual, 2022-05-31) — Salaries And Wages: 245000000.00
ORCL cash_flow (annual, 2022-05-31) — Sale Of Investment: 26151000000.00
ORCL income_statement (annual, 2022-05-31) — Selling And Marketing Expense: 8047000000.00
ORCL income_statement (annual, 2022-05-31) — Selling General And Administration: 9364000000.00
ORCL balance_sheet (annual, 2022-05-31) — Share Issued: 2665000000.00
ORCL cash_flow (annual, 2022-05-31) — Short Term Debt Issuance: 0.00
ORCL income_statement (annual, 2022-05-31) — Special Income Charges: -4904000000.00
ORCL cash_flow (annual, 2022-05-31) — Stock Based Compensation: 2613000000.00
ORCL balance_sheet (annual, 2022-05-31) — Stockholders Equity: -6220000000.00
ORCL balance_sheet (annual, 2022-05-31) — Tangible Book Value: -51471000000.00
ORCL income_statement (annual, 2022-05-31) — Tax Effect Of Unusual Items: -640500000.00
ORCL income_statement (annual, 2022-05-31) — Tax Provision: 932000000.00
ORCL income_statement (annual, 2022-05-31) — Tax Rate For Calcs: 0.12
ORCL balance_sheet (annual, 2022-05-31) — Total Assets: 109297000000.00
ORCL balance_sheet (annual, 2022-05-31) — Total Capitalization: 65890000000.00
ORCL balance_sheet (annual, 2022-05-31) — Total Debt: 75859000000.00
ORCL balance_sheet (annual, 2022-05-31) — Total Equity Gross Minority Interest: -5768000000.00
ORCL income_statement (annual, 2022-05-31) — Total Expenses: 26610000000.00
ORCL balance_sheet (annual, 2022-05-31) — Total Liabilities Net Minority Interest: 115065000000.00
ORCL balance_sheet (annual, 2022-05-31) — Total Non Current Assets: 77664000000.00
ORCL balance_sheet (annual, 2022-05-31) — Total Non Current Liabilities Net Minority Interest: 95554000000.00
ORCL income_statement (annual, 2022-05-31) — Total Operating Income As Reported: 10926000000.00
ORCL income_statement (annual, 2022-05-31) — Total Unusual Items: -5250000000.00
ORCL income_statement (annual, 2022-05-31) — Total Unusual Items Excluding Goodwill: -5250000000.00
ORCL balance_sheet (annual, 2022-05-31) — Tradeand Other Payables Non Current: 12210000000.00
ORCL balance_sheet (annual, 2022-05-31) — Working Capital: 12122000000.00
ORCL income_statement (annual, 2023-05-31) — +Operating Expense: 22617000000.00
ORCL income_statement (annual, 2023-05-31) — +Total Revenue: 49954000000.00
ORCL balance_sheet (annual, 2023-05-31) — Accounts Payable: 1204000000.00
ORCL balance_sheet (annual, 2023-05-31) — Accounts Receivable: 6915000000.00
ORCL balance_sheet (annual, 2023-05-31) — Accumulated Depreciation: -11605000000.00
ORCL balance_sheet (annual, 2023-05-31) — Allowance For Doubtful Accounts Receivable: -428000000.00
ORCL income_statement (annual, 2023-05-31) — Amortization: 3582000000.00
ORCL cash_flow (annual, 2023-05-31) — Amortization Cash Flow: 3582000000.00
ORCL cash_flow (annual, 2023-05-31) — Amortization Of Intangibles: 3582000000.00
ORCL income_statement (annual, 2023-05-31) — Amortization Of Intangibles Income Statement: 3582000000.00
ORCL income_statement (annual, 2023-05-31) — Basic Average Shares: 2696000000.00
ORCL income_statement (annual, 2023-05-31) — Basic EPS: 3.15
ORCL cash_flow (annual, 2023-05-31) — Beginning Cash Position: 21383000000.00
ORCL balance_sheet (annual, 2023-05-31) — Buildings And Improvements: 5880000000.00
ORCL cash_flow (annual, 2023-05-31) — Capital Expenditure: -8695000000.00
ORCL cash_flow (annual, 2023-05-31) — Capital Expenditure Reported: -8695000000.00
ORCL balance_sheet (annual, 2023-05-31) — Capital Stock: 30215000000.00
ORCL balance_sheet (annual, 2023-05-31) — Cash And Cash Equivalents: 9765000000.00
ORCL balance_sheet (annual, 2023-05-31) — Cash Cash Equivalents And Short Term Investments: 10187000000.00
ORCL cash_flow (annual, 2023-05-31) — Cash Dividends Paid: -3668000000.00
ORCL cash_flow (annual, 2023-05-31) — Cash Flow From Continuing Financing Activities: 7910000000.00
ORCL cash_flow (annual, 2023-05-31) — Cash Flow From Continuing Investing Activities: -36484000000.00
ORCL cash_flow (annual, 2023-05-31) — Cash Flow From Continuing Operating Activities: 17165000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Account Payable: -281000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Income Tax Payable: -153000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Other Working Capital: 781000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Payable: -434000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Payables And Accrued Expense: -434000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Prepaid Assets: 317000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Receivables: -151000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Tax Payable: -153000000.00
ORCL cash_flow (annual, 2023-05-31) — Change In Working Capital: 513000000.00
ORCL cash_flow (annual, 2023-05-31) — Changes In Account Receivables: -151000000.00
ORCL cash_flow (annual, 2023-05-31) — Changes In Cash: -11409000000.00
ORCL balance_sheet (annual, 2023-05-31) — Common Stock: 30215000000.00
ORCL cash_flow (annual, 2023-05-31) — Common Stock Dividend Paid: -3668000000.00
ORCL balance_sheet (annual, 2023-05-31) — Common Stock Equity: 1073000000.00
ORCL cash_flow (annual, 2023-05-31) — Common Stock Issuance: 1192000000.00
ORCL cash_flow (annual, 2023-05-31) — Common Stock Payments: -2503000000.00
ORCL balance_sheet (annual, 2023-05-31) — Construction In Progress: 3846000000.00
ORCL income_statement (annual, 2023-05-31) — Cost Of Revenue: 13564000000.00
ORCL balance_sheet (annual, 2023-05-31) — Current Assets: 21004000000.00
ORCL balance_sheet (annual, 2023-05-31) — Current Debt: 4061000000.00
ORCL balance_sheet (annual, 2023-05-31) — Current Debt And Capital Lease Obligation: 4061000000.00
ORCL balance_sheet (annual, 2023-05-31) — Current Deferred Liabilities: 8970000000.00
ORCL balance_sheet (annual, 2023-05-31) — Current Deferred Revenue: 8970000000.00
ORCL balance_sheet (annual, 2023-05-31) — Current Liabilities: 23090000000.00
ORCL cash_flow (annual, 2023-05-31) — Deferred Income Tax: -2167000000.00
ORCL cash_flow (annual, 2023-05-31) — Deferred Tax: -2167000000.00
ORCL cash_flow (annual, 2023-05-31) — Depreciation: 2526000000.00
ORCL cash_flow (annual, 2023-05-31) — Depreciation Amortization Depletion: 6108000000.00
ORCL income_statement (annual, 2023-05-31) — Depreciation Amortization Depletion Income Statement: 3582000000.00
ORCL cash_flow (annual, 2023-05-31) — Depreciation And Amortization: 6108000000.00
ORCL income_statement (annual, 2023-05-31) — Depreciation And Amortization In Income Statement: 3582000000.00
ORCL balance_sheet (annual, 2023-05-31) — Derivative Product Liabilities: -52000000.00
ORCL income_statement (annual, 2023-05-31) — Diluted Average Shares: 2766000000.00
ORCL income_statement (annual, 2023-05-31) — Diluted EPS: 3.07
ORCL income_statement (annual, 2023-05-31) — Diluted NI Availto Com Stockholders: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — EBIT: 12631000000.00
ORCL income_statement (annual, 2023-05-31) — EBITDA: 18739000000.00
ORCL income_statement (annual, 2023-05-31) — Earnings From Equity Interest: -165000000.00
ORCL cash_flow (annual, 2023-05-31) — Effect Of Exchange Rate Changes: -209000000.00
ORCL cash_flow (annual, 2023-05-31) — End Cash Position: 9765000000.00
ORCL cash_flow (annual, 2023-05-31) — Financing Cash Flow: 7910000000.00
ORCL cash_flow (annual, 2023-05-31) — Free Cash Flow: 8470000000.00
ORCL income_statement (annual, 2023-05-31) — Gain On Sale Of Security: -576000000.00
ORCL balance_sheet (annual, 2023-05-31) — Gains Losses Not Affecting Retained Earnings: -1522000000.00
ORCL income_statement (annual, 2023-05-31) — General And Administrative Expense: 1579000000.00
ORCL balance_sheet (annual, 2023-05-31) — Goodwill: 62261000000.00
ORCL balance_sheet (annual, 2023-05-31) — Goodwill And Other Intangible Assets: 72098000000.00
ORCL balance_sheet (annual, 2023-05-31) — Gross Accounts Receivable: 7343000000.00
ORCL balance_sheet (annual, 2023-05-31) — Gross PPE: 28674000000.00
ORCL income_statement (annual, 2023-05-31) — Gross Profit: 36390000000.00
ORCL cash_flow (annual, 2023-05-31) — Income Tax Paid Supplemental Data: 3009000000.00
ORCL income_statement (annual, 2023-05-31) — Interest Expense: 3505000000.00
ORCL income_statement (annual, 2023-05-31) — Interest Expense Non Operating: 3505000000.00
ORCL income_statement (annual, 2023-05-31) — Interest Income: 285000000.00
ORCL income_statement (annual, 2023-05-31) — Interest Income Non Operating: 285000000.00
ORCL cash_flow (annual, 2023-05-31) — Interest Paid Supplemental Data: 3250000000.00
ORCL balance_sheet (annual, 2023-05-31) — Invested Capital: 91554000000.00
ORCL cash_flow (annual, 2023-05-31) — Investing Cash Flow: -36484000000.00
ORCL cash_flow (annual, 2023-05-31) — Issuance Of Capital Stock: 1192000000.00
ORCL cash_flow (annual, 2023-05-31) — Issuance Of Debt: 33494000000.00
ORCL balance_sheet (annual, 2023-05-31) — Land And Improvements: 1243000000.00
ORCL balance_sheet (annual, 2023-05-31) — Long Term Debt: 86420000000.00
ORCL balance_sheet (annual, 2023-05-31) — Long Term Debt And Capital Lease Obligation: 86420000000.00
ORCL cash_flow (annual, 2023-05-31) — Long Term Debt Issuance: 33494000000.00
ORCL cash_flow (annual, 2023-05-31) — Long Term Debt Payments: -21050000000.00
ORCL balance_sheet (annual, 2023-05-31) — Machinery Furniture Equipment: 17705000000.00
ORCL balance_sheet (annual, 2023-05-31) — Minority Interest: 483000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Business Purchase And Sale: -27721000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Common Stock Issuance: -1311000000.00
ORCL balance_sheet (annual, 2023-05-31) — Net Debt: 80716000000.00
ORCL income_statement (annual, 2023-05-31) — Net Income: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — Net Income Common Stockholders: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — Net Income Continuous Operations: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — Net Income From Continuing And Discontinued Operation: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — Net Income From Continuing Operation Net Minority Interest: 8503000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Income From Continuing Operations: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — Net Income Including Noncontrolling Interests: 8503000000.00
ORCL income_statement (annual, 2023-05-31) — Net Interest Income: -3220000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Investment Purchase And Sale: -68000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Issuance Payments Of Debt: 12944000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Long Term Debt Issuance: 12444000000.00
ORCL income_statement (annual, 2023-05-31) — Net Non Operating Interest Income Expense: -3220000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Other Financing Charges: -55000000.00
ORCL balance_sheet (annual, 2023-05-31) — Net PPE: 17069000000.00
ORCL cash_flow (annual, 2023-05-31) — Net Short Term Debt Issuance: 500000000.00
ORCL balance_sheet (annual, 2023-05-31) — Net Tangible Assets: -71025000000.00
ORCL balance_sheet (annual, 2023-05-31) — Non Current Deferred Assets: 12226000000.00
ORCL balance_sheet (annual, 2023-05-31) — Non Current Deferred Liabilities: 5772000000.00
ORCL balance_sheet (annual, 2023-05-31) — Non Current Deferred Taxes Assets: 12226000000.00
ORCL balance_sheet (annual, 2023-05-31) — Non Current Deferred Taxes Liabilities: 5772000000.00
ORCL income_statement (annual, 2023-05-31) — Normalized EBITDA: 19995000000.00
ORCL income_statement (annual, 2023-05-31) — Normalized Income: 9673592000.00
ORCL cash_flow (annual, 2023-05-31) — Operating Cash Flow: 17165000000.00
ORCL income_statement (annual, 2023-05-31) — Operating Income: 13773000000.00
ORCL income_statement (annual, 2023-05-31) — Operating Revenue: 49954000000.00
ORCL balance_sheet (annual, 2023-05-31) — Ordinary Shares Number: 2713000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Current Assets: 3902000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Current Borrowings: 4061000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Current Liabilities: 6802000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Equity Adjustments: -1522000000.00
ORCL income_statement (annual, 2023-05-31) — Other Gand A: 1579000000.00
ORCL income_statement (annual, 2023-05-31) — Other Income Expense: -1427000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Intangible Assets: 9837000000.00
ORCL cash_flow (annual, 2023-05-31) — Other Non Cash Items: 661000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Non Current Assets: 11987000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Non Current Liabilities: 6469000000.00
ORCL income_statement (annual, 2023-05-31) — Other Non Operating Income Expenses: -6000000.00
ORCL income_statement (annual, 2023-05-31) — Other Operating Expenses: 103000000.00
ORCL balance_sheet (annual, 2023-05-31) — Other Short Term Investments: 422000000.00
ORCL balance_sheet (annual, 2023-05-31) — Payables: 1204000000.00
ORCL balance_sheet (annual, 2023-05-31) — Payables And Accrued Expenses: 1204000000.00
ORCL balance_sheet (annual, 2023-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 2053000000.00
ORCL balance_sheet (annual, 2023-05-31) — Preferred Stock: 0.00
ORCL income_statement (annual, 2023-05-31) — Pretax Income: 9126000000.00
ORCL balance_sheet (annual, 2023-05-31) — Properties: 0.00
ORCL cash_flow (annual, 2023-05-31) — Purchase Of Business: -27721000000.00
ORCL cash_flow (annual, 2023-05-31) — Purchase Of Investment: -1181000000.00
ORCL balance_sheet (annual, 2023-05-31) — Receivables: 6915000000.00
ORCL income_statement (annual, 2023-05-31) — Reconciled Cost Of Revenue: 11038000000.00
ORCL income_statement (annual, 2023-05-31) — Reconciled Depreciation: 6108000000.00
ORCL cash_flow (annual, 2023-05-31) — Repayment Of Debt: -21050000000.00
ORCL cash_flow (annual, 2023-05-31) — Repurchase Of Capital Stock: -2503000000.00
ORCL income_statement (annual, 2023-05-31) — Research And Development: 8623000000.00
ORCL income_statement (annual, 2023-05-31) — Restructuring And Mergern Acquisition: 680000000.00
ORCL balance_sheet (annual, 2023-05-31) — Retained Earnings: -27620000000.00
ORCL income_statement (annual, 2023-05-31) — Salaries And Wages: 363000000.00
ORCL cash_flow (annual, 2023-05-31) — Sale Of Investment: 1113000000.00
ORCL income_statement (annual, 2023-05-31) — Selling And Marketing Expense: 8833000000.00
ORCL income_statement (annual, 2023-05-31) — Selling General And Administration: 10412000000.00
ORCL balance_sheet (annual, 2023-05-31) — Share Issued: 2713000000.00
ORCL cash_flow (annual, 2023-05-31) — Short Term Debt Issuance: 500000000.00
ORCL income_statement (annual, 2023-05-31) — Special Income Charges: -680000000.00
ORCL cash_flow (annual, 2023-05-31) — Stock Based Compensation: 3547000000.00
ORCL balance_sheet (annual, 2023-05-31) — Stockholders Equity: 1073000000.00
ORCL balance_sheet (annual, 2023-05-31) — Tangible Book Value: -71025000000.00
ORCL income_statement (annual, 2023-05-31) — Tax Effect Of Unusual Items: -85408000.00
ORCL income_statement (annual, 2023-05-31) — Tax Provision: 623000000.00
ORCL income_statement (annual, 2023-05-31) — Tax Rate For Calcs: 0.07
ORCL balance_sheet (annual, 2023-05-31) — Total Assets: 134384000000.00
ORCL balance_sheet (annual, 2023-05-31) — Total Capitalization: 87493000000.00
ORCL balance_sheet (annual, 2023-05-31) — Total Debt: 90481000000.00
ORCL balance_sheet (annual, 2023-05-31) — Total Equity Gross Minority Interest: 1556000000.00
ORCL income_statement (annual, 2023-05-31) — Total Expenses: 36181000000.00
ORCL balance_sheet (annual, 2023-05-31) — Total Liabilities Net Minority Interest: 132828000000.00
ORCL balance_sheet (annual, 2023-05-31) — Total Non Current Assets: 113380000000.00
ORCL balance_sheet (annual, 2023-05-31) — Total Non Current Liabilities Net Minority Interest: 109738000000.00
ORCL income_statement (annual, 2023-05-31) — Total Operating Income As Reported: 13093000000.00
ORCL income_statement (annual, 2023-05-31) — Total Unusual Items: -1256000000.00
ORCL income_statement (annual, 2023-05-31) — Total Unusual Items Excluding Goodwill: -1256000000.00
ORCL balance_sheet (annual, 2023-05-31) — Tradeand Other Payables Non Current: 11077000000.00
ORCL balance_sheet (annual, 2023-05-31) — Working Capital: -2086000000.00
ORCL income_statement (annual, 2024-05-31) — +Operating Expense: 21747000000.00
ORCL income_statement (annual, 2024-05-31) — +Total Revenue: 52961000000.00
ORCL balance_sheet (annual, 2024-05-31) — Accounts Payable: 2357000000.00
ORCL balance_sheet (annual, 2024-05-31) — Accounts Receivable: 7874000000.00
ORCL balance_sheet (annual, 2024-05-31) — Accumulated Depreciation: -13282000000.00
ORCL balance_sheet (annual, 2024-05-31) — Allowance For Doubtful Accounts Receivable: -485000000.00
ORCL income_statement (annual, 2024-05-31) — Amortization: 3010000000.00
ORCL cash_flow (annual, 2024-05-31) — Amortization Cash Flow: 3010000000.00
ORCL cash_flow (annual, 2024-05-31) — Amortization Of Intangibles: 3010000000.00
ORCL income_statement (annual, 2024-05-31) — Amortization Of Intangibles Income Statement: 3010000000.00
ORCL income_statement (annual, 2024-05-31) — Basic Average Shares: 2744000000.00
ORCL income_statement (annual, 2024-05-31) — Basic EPS: 3.82
ORCL cash_flow (annual, 2024-05-31) — Beginning Cash Position: 9765000000.00
ORCL balance_sheet (annual, 2024-05-31) — Buildings And Improvements: 6493000000.00
ORCL cash_flow (annual, 2024-05-31) — Capital Expenditure: -6866000000.00
ORCL cash_flow (annual, 2024-05-31) — Capital Expenditure Reported: -6866000000.00
ORCL balance_sheet (annual, 2024-05-31) — Capital Lease Obligations: 6255000000.00
ORCL balance_sheet (annual, 2024-05-31) — Capital Stock: 32764000000.00
ORCL balance_sheet (annual, 2024-05-31) — Cash And Cash Equivalents: 10454000000.00
ORCL balance_sheet (annual, 2024-05-31) — Cash Cash Equivalents And Short Term Investments: 10661000000.00
ORCL cash_flow (annual, 2024-05-31) — Cash Dividends Paid: -4391000000.00
ORCL cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Financing Activities: -10554000000.00
ORCL cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Investing Activities: -7360000000.00
ORCL cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Operating Activities: 18673000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Account Payable: -594000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Income Tax Payable: -127000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Other Working Capital: 656000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Payable: -721000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Payables And Accrued Expense: -721000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Prepaid Assets: 542000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Receivables: -965000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Tax Payable: -127000000.00
ORCL cash_flow (annual, 2024-05-31) — Change In Working Capital: -488000000.00
ORCL cash_flow (annual, 2024-05-31) — Changes In Account Receivables: -965000000.00
ORCL cash_flow (annual, 2024-05-31) — Changes In Cash: 759000000.00
ORCL balance_sheet (annual, 2024-05-31) — Common Stock: 32764000000.00
ORCL cash_flow (annual, 2024-05-31) — Common Stock Dividend Paid: -4391000000.00
ORCL balance_sheet (annual, 2024-05-31) — Common Stock Equity: 8704000000.00
ORCL cash_flow (annual, 2024-05-31) — Common Stock Issuance: 742000000.00
ORCL cash_flow (annual, 2024-05-31) — Common Stock Payments: -3242000000.00
ORCL balance_sheet (annual, 2024-05-31) — Construction In Progress: 5634000000.00
ORCL income_statement (annual, 2024-05-31) — Cost Of Revenue: 15143000000.00
ORCL balance_sheet (annual, 2024-05-31) — Current Assets: 22554000000.00
ORCL balance_sheet (annual, 2024-05-31) — Current Debt: 10605000000.00
ORCL balance_sheet (annual, 2024-05-31) — Current Debt And Capital Lease Obligation: 10605000000.00
ORCL balance_sheet (annual, 2024-05-31) — Current Deferred Liabilities: 9313000000.00
ORCL balance_sheet (annual, 2024-05-31) — Current Deferred Revenue: 9313000000.00
ORCL balance_sheet (annual, 2024-05-31) — Current Liabilities: 31544000000.00
ORCL cash_flow (annual, 2024-05-31) — Deferred Income Tax: -2139000000.00
ORCL cash_flow (annual, 2024-05-31) — Deferred Tax: -2139000000.00
ORCL cash_flow (annual, 2024-05-31) — Depreciation: 3129000000.00
ORCL cash_flow (annual, 2024-05-31) — Depreciation Amortization Depletion: 6139000000.00
ORCL income_statement (annual, 2024-05-31) — Depreciation Amortization Depletion Income Statement: 3010000000.00
ORCL cash_flow (annual, 2024-05-31) — Depreciation And Amortization: 6139000000.00
ORCL income_statement (annual, 2024-05-31) — Depreciation And Amortization In Income Statement: 3010000000.00
ORCL income_statement (annual, 2024-05-31) — Diluted Average Shares: 2823000000.00
ORCL income_statement (annual, 2024-05-31) — Diluted EPS: 3.71
ORCL income_statement (annual, 2024-05-31) — Diluted NI Availto Com Stockholders: 10467000000.00
ORCL income_statement (annual, 2024-05-31) — EBIT: 15255000000.00
ORCL income_statement (annual, 2024-05-31) — EBITDA: 21394000000.00
ORCL income_statement (annual, 2024-05-31) — Earnings From Equity Interest: -186000000.00
ORCL cash_flow (annual, 2024-05-31) — Effect Of Exchange Rate Changes: -70000000.00
ORCL cash_flow (annual, 2024-05-31) — End Cash Position: 10454000000.00
ORCL cash_flow (annual, 2024-05-31) — Financing Cash Flow: -10554000000.00
ORCL cash_flow (annual, 2024-05-31) — Free Cash Flow: 11807000000.00
ORCL income_statement (annual, 2024-05-31) — Gain On Sale Of Security: -531000000.00
ORCL balance_sheet (annual, 2024-05-31) — Gains Losses Not Affecting Retained Earnings: -1432000000.00
ORCL income_statement (annual, 2024-05-31) — General And Administrative Expense: 1548000000.00
ORCL balance_sheet (annual, 2024-05-31) — Goodwill: 62230000000.00
ORCL balance_sheet (annual, 2024-05-31) — Goodwill And Other Intangible Assets: 69120000000.00
ORCL balance_sheet (annual, 2024-05-31) — Gross Accounts Receivable: 8359000000.00
ORCL balance_sheet (annual, 2024-05-31) — Gross PPE: 34818000000.00
ORCL income_statement (annual, 2024-05-31) — Gross Profit: 37818000000.00
ORCL cash_flow (annual, 2024-05-31) — Income Tax Paid Supplemental Data: 3560000000.00
ORCL income_statement (annual, 2024-05-31) — Interest Expense: 3514000000.00
ORCL income_statement (annual, 2024-05-31) — Interest Expense Non Operating: 3514000000.00
ORCL income_statement (annual, 2024-05-31) — Interest Income: 451000000.00
ORCL income_statement (annual, 2024-05-31) — Interest Income Non Operating: 451000000.00
ORCL cash_flow (annual, 2024-05-31) — Interest Paid Supplemental Data: 3655000000.00
ORCL balance_sheet (annual, 2024-05-31) — Invested Capital: 95573000000.00
ORCL cash_flow (annual, 2024-05-31) — Investing Cash Flow: -7360000000.00
ORCL cash_flow (annual, 2024-05-31) — Issuance Of Capital Stock: 742000000.00
ORCL cash_flow (annual, 2024-05-31) — Issuance Of Debt: 0.00
ORCL balance_sheet (annual, 2024-05-31) — Land And Improvements: 1239000000.00
ORCL balance_sheet (annual, 2024-05-31) — Long Term Capital Lease Obligation: 6255000000.00
ORCL balance_sheet (annual, 2024-05-31) — Long Term Debt: 76264000000.00
ORCL balance_sheet (annual, 2024-05-31) — Long Term Debt And Capital Lease Obligation: 82519000000.00